{"filing":{"accession_number":"0001493152-26-029119","cik":"0002010788","ticker":"EXOZ","company_name":"EXOZYMES INC.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226029119/form8-k.htm"},"events":[{"id":11646,"run_id":10230,"accession_number":"0001493152-26-029119","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a firm commitment underwritten offering of 592,270 shares of common stock and 296,135 warrants, with gross proceeds of approximately $5.95 million (inclusive of over-allotment exercise). This is a registered equity issuance under an effective S-3 shelf registration statement, representing a dilutive capital raise material to investors' assessment of ownership and capital structure.","company_name":"EXOZYMES INC.","ticker":"EXOZ","filing_date":"2026-06-17","submitted_at":null,"items":null}],"classifications":[{"id":8291,"accession_number":"0001493152-26-029119","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a firm commitment underwritten offering of 592,270 shares of common stock and 296,135 warrants, with gross proceeds of approximately $5.95 million (inclusive of over-allotment exercise). This is a registered equity issuance under an effective S-3 shelf registration statement, representing a dilutive capital raise material to investors' assessment of ownership and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T21:12:08.045433+00:00","company_name":"EXOZYMES INC.","ticker":"EXOZ","filing_date":"2026-06-17"}]}